Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma

M Partanen1, D L Anghelescu2, L Hall2

  • 1Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

European Journal of Cancer (Oxford, England : 1990)
|March 20, 2021
PubMed

Insights

Longer anesthesia exposure is linked to neurocognitive decline in pediatric medulloblastoma survivors. Limiting anesthesia may improve long-term quality of life for these children.

Area of Science:

  • Pediatric Oncology
  • Neuroscience
  • Anesthesiology

Background:

  • Pediatric medulloblastoma treatment often involves anesthesia.
  • Long-term neurocognitive effects are a concern for survivors.
  • The association between anesthesia exposure and neurocognitive decline requires further investigation.

Purpose of the Study:

  • To determine if anesthesia exposure correlates with neurocognitive decline in pediatric medulloblastoma patients.
  • To identify specific neurocognitive domains affected by anesthesia duration.

Main Methods:

  • 107 pediatric medulloblastoma patients from a clinical trial were analyzed.
  • Neurocognitive assessments were conducted annually for 5 years.
  • Anesthesia exposure data was abstracted from medical records.

Main Results:

  • Longer anesthesia duration was significantly associated with declines in IQ, attention, and processing speed.
  • These associations were consistent across various subgroups, including different age groups and risk levels.
  • Mean cumulative anesthesia duration was 20.4 hours.

Conclusions:

  • Increased anesthesia exposure is a risk factor for neurocognitive decline in pediatric medulloblastoma survivors.
  • Strategies to limit anesthesia exposure may help mitigate long-term neurocognitive deficits.
  • Reducing anesthesia exposure could enhance the quality of life for survivors.
Abstract

Related Concept Videos